Reconnecting

The current page stays visible while onset.to reconnects in the background.

Psilocybin produces different behavioral and brain-altering effects depending on the dose

Open original

Psilocybin dose appears to produce distinct behavioral outcomes and different markers of neuroplasticity in mice, linking receptor engagement to potential anxiolytic versus antidepressant-like effects. In a mouse study, researchers measured 5-HT2A receptor occupancy in the prefrontal cortex and compared it with drug effects on head twitch behavior and later behavioral assays. Moderate dosing was associated with reduced anxiety-like behavior in an elevated maze, while higher dosing produced antidepressant-like effects in a forced swim test. The brain analyses focused on markers of cellular plasticity. Both moderate and high doses increased microtubule dynamics in mood-relevant regions, but increases in synaptic protein markers occurred in the prefrontal cortex only, not the amygdala. The findings support a region-specific response to psychedelic receptor activation and suggest that “stronger” does not necessarily mean “better” for therapeutic outcomes.